Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | POLR2D | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | MRPS22 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
mRNA | DGKE | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | SETD1B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | PDE6B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | DDX39B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | TBC1D31 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | CCDC188 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | DDB2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | VN1R1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |